Search results
Results From The WOW.Com Content Network
(Reuters) -The U.S. Food and Drug Administration has approved Elanco Animal Health's skin disease treatment for dogs, the health regulator's website showed on Thursday, sending the company's ...
Tigilanol tiglate (USAN; [1]), sold under the brand name Stelfonta is a medication used to treat dogs with non-metastatic, skin-based mast cell tumors (MCTs). The FDA is also approving Stelfonta to treat non-metastatic MCTs located under the dog's skin (subcutaneous), in particular areas of a dog's leg. [2]
The drug is FDA-approved for prevention of heartworm in dogs and cats, [4] although it is less potent against heartworms than ivermectin. [citation needed] The substance is often combined with other parasiticides to achieve a broader spectrum of action. Such products include: [citation needed] Milbemax and Interceptor Plus (with praziquantel)
Bravecto 1-Month was approved by the FDA in November 2024 for the addition of the indication for the treatment and control of Haemaphysalis longicornis (Asian longhorned tick) infestations for one month in dogs and puppies eigjht weeks of age and older, and weighing 4.4 pounds (2.0 kg) or greater.
"Flea treatments meant for dogs can be deadly if given to cats instead. It is important to use only flea and tick products specifically designed for cats, and to administer the proper dosage," the ...
The drug, branded as Credelio Quattro, is a single, monthly chewable tablet for dogs eight weeks of age or older, the company said. The drug is approved for the treatment of flea and tick ...
Most of the other contraindications are avoiding cases where a potential side effect exacerbates a pre-existing condition: for example, because oclacitinib can cause lumps or tumors, it should not be used in dogs with cancer or a history of it; [15] because it is an immune system suppressant, it should not be used in dogs with serious infections.
pharmacological – No drug has been approved by the U.S. Food and Drug Administration (FDA) for treating tinnitus. However, various pharmacological treatments, including antidepressants, anxiolytics, vasodilators and vasoactive substances, and intravenous lidocaine have been prescribed for tinnitus [21]